T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off from the University of Basel is developing a targeted cancer…
Closing a deal is more art than science. This is especially true in the biopharma industry where investments and partnerships are key elements to success.…
Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round Basel, Switzerland, 28 March 2019–Polyneuron…
Basel – Scientists at the ETH Zurich’s Department of Biosystems in Basel have developed a storage mechanism that can provide insight into the history of…
Danish company Novo Holdings is investing 6.8 million Swiss francs in the biopharmaceutical Polyphor from the canton of Basel-Landschaft. As a result, it hopes to…
Switzerland’s first electronic health record has been opened in Basel. The University Hospital Basel will soon be offering the service to patients at its clinics.
Terpenes are a class of chemical compounds found in nature that also include clinical substances. Lab synthesis has always been very difficult, but Basel scientists…
Switzerland Innovation Park Basel Area offers fully equipped plug & play labs for early stage life sciences projects and startups, ideal for aspiring founders.